14th January 2012 - 08:29 AM
QUOTE (tonnymjohnson+Jan 13 2012, 09:13 PM)
Recent US FDA approval of Genentech’s Herceptin® with DakoCytomation’s HercepTest® for breast cancer theranostics is a very good example. We will see more approvals in future.
Nice to hear that your research interests are in this filed. We will find some time to discuss more on this topic.
20th February 2012 - 04:16 AM
This is new forum site for me. I like this forum. I got lots of nice information from your site. Thanks...
20th February 2012 - 02:44 PM
I'm on the other side of the anti-cancer research, working to make the generics more palatable for patients.
Let's meet in the middle, and kick cancer's ***.
(To our audience, cancer research is becoming increasinly underfunded. The gov't has to cut back. Pharma is cutting back. And people are donating less to the charities. It would *really* help if you spun some of your luxury spending into cancer donations. And it would help even more if you could get people to copy that type of behaviour)